Precision Biopsy Garners $33,600,000 New Funding

  • Feed Type
  • Date
  • Company Name
    Precision Biopsy
  • Mailing Address
    12705 East Montview Blvd. Aurora, CO 80045 USA
  • Company Description
    Precision Biopsy sits squarely at the intersection of machine and molecular biology in the service of improving human health, and is backed by Allied Minds, a premier firm for commercializing early-stage technology. We create purposeful diagnostic devices that can better guide early intervention through real-time detection of suspicious tissue during biopsy exams.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Precision Biopsy announced that it successfully raised $33.6 million in new equity investments as the company embarks on a global commercialization strategy for its ClariCore™ Biopsy System, a device platform designed to provide accurate, real-time classification of prostate tissue during biopsy procedures. The company also plans to accelerate the development of its Focal Therapy program, which seeks to provide targeted, localized therapy to the prostate gland by using the same optical tissue-targeting technology found in the ClariCore system.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy